A Double-blind Placebo Controlled Study of Desipramine in the Treatment of ADD: II. Serum Drug Levels and Cardiovascular Findings
- 1 November 1989
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 28 (6) , 903-911
- https://doi.org/10.1097/00004583-198911000-00015
Abstract
No abstract availableKeywords
Funding Information
- Merrell-Dow Pharmaceutical Company and the Charlupski Foundation (MH-31154, MH-36224. and MH-47370)
This publication has 27 references indexed in Scilit:
- Child and Adolescent Nortriptyline Single Dose Pharmacokinetic ParametersJournal of Clinical Psychopharmacology, 1987
- Imipramine in adolescent major depression: plasma level and clinical responseActa Psychiatrica Scandinavica, 1986
- Cardiovascular effects of desipramine in children and adolescents with attention deficit disorderThe Journal of Pediatrics, 1985
- Tricyclic Antidepressant and Methylphenidate Treatment of Attention Deficit Disorder in ChildrenJournal of the American Academy of Child Psychiatry, 1983
- Cardiovascular Effects of Tricyclic Antidepressants in Depressed Patients with Chronic Heart DiseaseNew England Journal of Medicine, 1982
- Pharmacokinetics of psychotropic drugs: What can it tell us?Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSIONThe Lancet, 1979
- EKG Effects of Imipramine Treatment in ChildrenJournal of the American Academy of Child Psychiatry, 1979
- Plasma Levels of Imipramine (IMI) and Desmethylimipramine (DMI) and Clinical Response in Prepubertal Major Depressive Disorder: A Preliminary ReportJournal of the American Academy of Child Psychiatry, 1979
- Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of the anesthetized dogsEuropean Journal of Pharmacology, 1977